Daewoong Co., Ltd.
Daewoong Co., Ltd., together with its subsidiaries, manufactures and sells pharmaceuticals. It also engages in the leasing of real estates. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd.
Drug Manufacturers - General
KR, Hwaseong-si [HQ]
003090.KS/Financial Reporting
Income Statements
15 Sheets · Starting from 2009In Million KRW. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 766,644.00 | 670,825.00 | 270,641.00 | 306,154.00 | 843,534.00 | 893,976.00 | 996,645.00 | 1,015,010.00 | 1,124,075.00 | 1,231,173.00 | 1,365,679.00 | 1,355,337.00 | 1,511,373.00 | 1,697,338.00 | 1,815,103.00 | |
|
EPS
|
475.15 | 768.35 | 1,027.18 | 1,051.00 | 963.20 | 558.80 | 906.60 | 92.00 | 1,534.00 | 692.00 | 1,423.96 | 2,343.12 | 1,894.69 | 2,466.88 | 3,691.68 | |
| Diluted in mil. | 475.15 | 768.35 | 1,027.18 | 1,051.00 | 963.20 | 558.80 | 906.60 | 92.00 | 1,534.00 | 692.00 | 1,423.96 | 2,343.12 | 1,894.69 | 2,466.88 | 3,691.68 | |
|
Profit
|
339,090.00 | 293,998.00 | 88,969.00 | 107,201.00 | 386,063.00 | 358,199.00 | 389,416.00 | 460,609.00 | 514,948.00 | 547,574.00 | 633,386.00 | 626,457.00 | 763,172.00 | 899,651.00 | 924,501.00 | |
| Gross Margin | 44.23 | 43.83 | 32.87 | 35.02 | 45.77 | 40.07 | 39.07 | 45.38 | 45.81 | 44.48 | 46.38 | 46.22 | 50.50 | 53.00 | 50.93 | |
| Pre Tax | 88,908.00 | 90,020.00 | 49,571.00 | 50,608.00 | 96,616.00 | 66,974.00 | 80,322.00 | 57,156.00 | 83,516.00 | 60,775.00 | 81,287.00 | 144,617.00 | 113,384.00 | 154,932.00 | 203,784.00 | |
| Profit Margin | 11.60 | 13.42 | 18.32 | 16.53 | 11.45 | 7.49 | 8.06 | 5.63 | 7.43 | 4.94 | 5.95 | 10.67 | 7.50 | 9.13 | 11.23 | |
| ETR | 62.24 | 28.97 | 10.29 | 8.43 | 22.66 | 43.45 | 32.04 | 39.51 | -2.62 | 46.14 | 12.23 | 18.14 | 11.84 | 22.37 | 5.44 | |
| Net | 20,011.00 | 32,363.00 | 43,268.00 | 44,199.00 | 40,771.00 | 23,811.00 | 38,623.00 | 19,831.00 | 66,250.00 | 29,863.00 | 62,439.00 | 98,378.00 | 78,730.00 | 102,565.00 | 152,665.00 | |
| Profit Margin | 2.61 | 4.82 | 15.99 | 14.44 | 4.83 | 2.66 | 3.88 | 1.95 | 5.89 | 2.43 | 4.57 | 7.26 | 5.21 | 6.04 | 8.41 | |
| EBITDA | 138,002.00 | 108,556.00 | 38,405.00 | 48,892.00 | 133,577.00 | 111,991.00 | 121,245.00 | 101,734.00 | 146,599.00 | 151,758.00 | 153,126.00 | 200,600.00 | 173,966.00 | 224,512.00 | 248,436.00 | |
| EBITDA Margin | 18.00 | 16.18 | 14.19 | 15.97 | 15.84 | 12.53 | 12.17 | 10.02 | 13.04 | 12.33 | 11.21 | 14.80 | 11.51 | 13.23 | 13.69 | |
| Operating Income | 97,710.00 | 90,242.00 | 49,904.00 | 43,504.00 | 97,202.00 | 78,669.00 | 79,718.00 | 60,994.00 | 84,543.00 | 85,774.00 | 107,543.00 | 149,751.00 | 123,408.00 | 207,334.00 | 195,872.00 | |
| Operating Margin | 12.75 | 13.45 | 18.44 | 14.21 | 11.52 | 8.80 | 8.00 | 6.01 | 7.52 | 6.97 | 7.87 | 11.05 | 8.17 | 12.22 | 10.79 | |
| Interest Income | 6,457.00 | 3,698.00 | 950.00 | 1,528.00 | 4,097.00 | 4,596.00 | 4,884.00 | 4,575.00 | 3,911.00 | 4,316.00 | 4,922.00 | 4,838.00 | 4,279.00 | 11,443.00 | 9,295.00 | |
| Loss | -668,933.00 | -580,582.00 | -243,795.00 | -277,266.00 | -746,112.00 | -815,282.00 | -917,097.00 | -953,971.00 | -1,039,413.00 | -1,145,515.00 | -1,258,135.00 | -1,257,282.00 | -1,328,746.00 | -1,490,004.00 | -1,619,230.00 | |
| Cost of Revenue | -427,553.00 | -376,826.00 | -181,671.00 | -198,953.00 | -457,470.00 | -535,776.00 | -607,229.00 | -554,400.00 | -609,127.00 | -683,598.00 | -732,292.00 | -728,880.00 | -748,200.00 | -797,686.00 | -890,602.00 | |
|
Operating Expenses
|
-241,380.00 | -203,755.00 | -62,123.00 | -78,313.00 | -288,641.00 | -279,505.00 | -309,867.00 | -399,571.00 | -430,286.00 | -461,916.00 | -525,842.00 | -528,401.00 | -580,545.00 | -692,317.00 | -728,628.00 | |
| R&D | -12,308.00 | -6,436.00 | -11,105.00 | -8,099.00 | -23,019.00 | -27,461.00 | -40,865.00 | -112,694.00 | -120,546.00 | -131,468.00 | -123,954.00 | -118,851.00 | -134,259.00 | -169,887.00 | -177,431.00 | |
| G&A | -39,179.00 | -21,336.00 | -4,375.00 | -7,140.00 | -28,858.00 | -26,887.00 | -30,413.00 | -31,287.00 | -29,993.00 | -29,582.00 | -27,033.00 | -21,640.00 | -23,035.00 | -25,339.00 | -27,124.00 | |
| SG&A | -118,919.00 | -103,458.00 | -15,577.00 | -25,985.00 | -127,272.00 | -118,257.00 | -119,816.00 | -135,933.00 | -156,274.00 | -188,655.00 | -253,399.00 | -261,297.00 | -290,729.00 | -341,204.00 | -545,505.00 | |
| S&M | -79,740.00 | -82,122.00 | -11,201.00 | -18,845.00 | -98,414.00 | -91,369.00 | -89,403.00 | -104,645.00 | -126,280.00 | -159,073.00 | -226,365.00 | -239,657.00 | -267,694.00 | -315,864.00 | -348,531.00 | |
| Depreciation and Amortization | -19,021.00 | -15,712.00 | -10,474.00 | -12,734.00 | -30,252.00 | -30,143.00 | -36,760.00 | -38,785.00 | -50,216.00 | -59,061.00 | -49,881.00 | -50,848.00 | -50,557.00 | -48,279.00 | -52,563.00 | |
| Interest Expenses | -5,800.00 | -3,912.00 | -1,273.00 | -2,081.00 | -1,930.00 | -2,271.00 | -3,802.00 | -4,956.00 | -8,487.00 | -9,596.00 | -10,099.00 | -10,505.00 | -10,292.00 | -8,351.00 | -17,106.00 | |
| Other Expenses | -8,801.00 | -222.00 | -21,640.00 | -7,103.00 | -586.00 | -11,695.00 | -603.00 | -3,837.00 | -1,026.00 | -24,999.00 | -26,256.00 | -5,134.00 | -10,024.00 | -52,402.00 | -7,911.00 | |
|
WA Shares Outstanding
|
42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 43.00 | 43.00 | 43.00 | 43.00 | 41.00 | 41.00 | 41.00 | 41.00 | |
| Diluted | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 43.00 | 43.00 | 43.00 | 43.00 | 41.00 | 41.00 | 41.00 | 41.00 |